VOYA Investment Management’s GALENA BIOPHARMA INC COM RXII Stock Holding History

VOYA Investment Management’s Portfolio RXII Stock Details RXII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-82,079	Closed	-$29	–	2570
2016 Q3	$29	Hold	82,079	–	–	﹤0.01%	2534
2016 Q2	$38K	Buy	82,079 +9,349	+13%	+$4.33K	﹤0.01%	2550
2016 Q1	$99K	Hold	72,730	–	–	﹤0.01%	2400
2015 Q4	$107K	Hold	72,730	–	–	﹤0.01%	2469
2015 Q3	$115K	Sell	72,730 -30,855	-30%	-$48.8K	﹤0.01%	2460
2015 Q2	$176K	Hold	103,585	–	–	﹤0.01%	2524
2015 Q1	$144K	Hold	103,585	–	–	﹤0.01%	2499
2014 Q4	$156K	Hold	103,585	–	–	﹤0.01%	2533
2014 Q3	$213K	Hold	103,585	–	–	﹤0.01%	2460
2014 Q2	$317K	Sell	103,585 -9,818	-9%	-$30K	﹤0.01%	2309
2014 Q1	$284K	Buy	+113,403	New	+$284K	﹤0.01%	2357

VOYA Investment Management's RXII Position: Q4 2016 in Review

VOYA Investment Management sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 82,079 shares — an estimated $29 sold.

VOYA Investment Management first reported a position in RXII in Q1 2014 and held it in 11 quarters. The position peaked at $317K in Q2 2014. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.

VOYA Investment Management reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
VOYA Investment Management sold 82,079 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $29.
VOYA Investment Management first reported a position in GALENA BIOPHARMA INC COM in Q1 2014 and held it in 11 quarters.
VOYA Investment Management's GALENA BIOPHARMA INC COM position peaked at $317K in Q2 2014.
0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.

Based on VOYA Investment Management's 13F filing for Q4 2016, filed 14 Feb 2017.